Campto Indications/Uses



The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
CAMPTO (irinotecan hydrochloride) is indicated for the treatment of patients with advanced colorectal cancer: In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for advanced disease; as a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.
Irinotecan combination with cisplatin is indicated for treatment of patients with small-cell lung cancer.
Strictly follow the recommended dosage unless directed otherwise by the physician.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in